Topic
cov
Knowledge-graph topic · documents ABOUT cov across the archive
Documents about cov
- CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2)#623553ClinicalTrials.gov
- Hydroxychloroquine to Prevent SARS-CoV-2 Infection/COVID-19#868488ClinicalTrials.gov
- A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid Proteins#813540ClinicalTrials.gov
- Quantifying the impact of social activities on SARS-CoV-2 transmission using Google mobility reports#162571PLOS
- Persistence and UV inactivation of SARS-CoV-2 in wastewater: Experimental characterization of time, temperature, and aerosolization effects#143892PLOS
- Evaluation and estimation of epidemic trajectories for SARS-CoV-2 from clinical and wastewater data in Gauteng Province, South Africa#160479PLOS
- Occupational risk factors for depression and anxiety symptoms: Insights from a large cohort study during and after the SARS-CoV-2 pandemic#13955PLOS
- SARS-CoV-2 infection in female sex workers from Nairobi, Kenya early in the COVID-19 pandemic: Seroincidence and behavioural associations#281559PLOS
- All‑cause excess mortality in Germany peaked during the late‑2022 influenza period, exceeding peaks during SARS‑CoV‑2 waves (2020–2023)#289119PLOS
- The SARS-CoV-2 Integrated Genomic Epidemiology Database (IGED): Linking viral genomes with patient-level metadata to advance statewide genomic surveillance in California#626365PLOS
- Sars-COV-2 (COVID-19) Immunity in immunoCOmpromised Populations#152492ClinicalTrials.gov
- CoV-ICU Score, Intensive Care Unit, SARS-CoV-2#859368ClinicalTrials.gov
- SARS-CoV-2 Sequenzdaten aus Deutschland#14667DataCite
- SARS-CoV-2 Sequenzdaten aus Deutschland#124848DataCite
- Clinical Trial of SARS-CoV-2 mRNA Vaccine in Chinese People#238172ClinicalTrials.gov
- AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning#679670PLOS
- Potential airborne transmission of SARS-COV-2 through bathroom ventilation ducts associated with an outbreak in a residential building in Santander, Spain, 2020#174833PLOS
- High prevalence of SARS-CoV-2 antibodies among frontline healthcare workers during the COVID-19 pandemic in three states of Nigeria from August to December 2022#443306PLOS
- ViralMultiNet: A structure-aware multimodal framework for viral protein function prediction in wastewater surveillance#255564PLOS
- Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection#803850ClinicalTrials.gov
- SARS-CoV-2 Infektionen in Deutschland#11935DataCite
- SARS-CoV-2 Infektionen in Deutschland#13349DataCite
- SARS-CoV-2 Infektionen in Deutschland#14623DataCite
- SARS-CoV-2 Infektionen in Deutschland#20804DataCite
- SARS-CoV-2 Infektionen in Deutschland#28896DataCite
- GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)#256950ClinicalTrials.gov
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)#369807ClinicalTrials.gov
- Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population#640437ClinicalTrials.gov
- Neurological Outcome After SARS-CoV-2 Infection#864140ClinicalTrials.gov
- Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa#828202ClinicalTrials.gov
- Association between parenthood and survival among 30,386 patients hospitalized with COVID-19#120216PLOS
- Human mobility and outbreak origins in epidemic spread: Insights from agent-based modeling#174824PLOS
- Accounting for the long-distance transmission route: An epidemiological model of airborne disease transmission in hospitals#425488PLOS
- COVID-19 vaccine effectiveness in preventing severe outcomes and assessing the impact of prior SARS-CoV-2 infection among hospitalized adults in Albania, July 2022-July 2023#174827PLOS
- SARS-CoV-2 spike protein diversity at an intra-host level, among SARS-CoV-2 infected individuals in South Africa, 2020 to 2022#365515SUNScholar
- Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a#832748ClinicalTrials.gov
- Association between coronavirus disease 2019 and new-onset autoimmune diseases during the early phase of the pandemic#154967PLOS
- Anticoagulación en pacientes con neumonía severa por SARS-CoV-2 en UCI#347024DIALNET OAI Articles
- Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers#394623ClinicalTrials.gov
- A STUDY ON NEUROPSYCHIATRIC IMPACTS OF SARS- COV-2 PANDEMIC#638701AGPE THE ROYAL GONDWANA RESEARCH JOURNAL OF HISTORY, SCIENCE, ECONOMIC, POLITICAL AND SOCIAL SCIENCE
- Subacute Thyroiditis in the SARS-CoV-2 Era#840487ClinicalTrials.gov
- Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine Booster#856634ClinicalTrials.gov
- Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines#865847ClinicalTrials.gov
- Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic#302068PLOS
- From sequences to strategies: Early detection of new SARS-CoV-2 variants via genetic distance to reduce hospitalizations#631449PLOS
- SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis#253078ClinicalTrials.gov
- The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.#275606NCBI PubMed Central
- Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants#463757ClinicalTrials.gov
- Electrocardiogram Analysis in COVID-19 Patients#803582ClinicalTrials.gov
- Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen#831634ClinicalTrials.gov
Related topics
Topic record · derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.